We are live on ! Find out more
RAM

Readystate Asset Management Portfolio holdings

AUM $2.23B
1-Year Est. Return 15%
This Fund
S&P 500
This Quarter Est. Return
+5.72%
1 Year Est. Return
+15%
3 Year Est. Return
+34.71%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$3.27B
AUM Growth
+$265M
Cap. Flow
-$778M
Cap. Flow %
-23.81%
Top 10 Hldgs %
40.43%
Holding
979
New
382
Increased
76
Reduced
85
Closed
388

Top Buys

Rank Stock Value
1
HSY icon
Hershey
HSY
+$72.5M
2
EXAS
Exact Sciences
EXAS
+$45.4M
3
BPMC
Blueprint Medicines
BPMC
+$34.3M
4
JNPR
Juniper Networks
JNPR
+$31.8M
5
AVTR icon
Avantor
AVTR
+$27.5M

Top Sells

Rank Stock Value
1
ITCI
Intra-Cellular Therapies Inc.
ITCI
+$66.9M
2
K
Kellanova
K
+$60.1M
3
FYBR
Frontier Communications
FYBR
+$50.1M
4
X
US Steel
X
+$34.4M
5
LQD icon
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
+$31.8M

Sector Composition

Rank Sector Weight
1 Healthcare 13.19%
2 Technology 6.26%
3 Consumer Discretionary 3.33%
4 Consumer Staples 2.88%
5 Communication Services 2.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SRDX
26
DELISTED
Surmodics
SRDX
$12.9M 0.39%
+433,612
New +$12.5M
BASE
27
DELISTED
Couchbase
BASE
$12.8M 0.39%
524,702
+313,184
+148% +$5.69M
IMNM icon
28
Immunome
IMNM
$2.52B
$12.6M 0.39%
1,353,586
+1,129,346
+504% +$9.26M
HES
29
DELISTED
Hess
HES
$11.3M 0.35%
81,913
-170,225
-68% -$23M
KVUE icon
30
CALL
Kenvue
KVUE
$37B
$10.5M 0.32%
+500,000
New +$11.4M
BBIO icon
31
BridgeBio Pharma
BBIO
$16.5B
$10.4M 0.32%
+240,883
New +$8.76M
EMB icon
32
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
$14.9B
$9.92M 0.3%
+107,059
New +$9.64M
AXSM icon
33
Axsome Therapeutics
AXSM
$12.4B
$9.87M 0.3%
94,571
+35,018
+59% +$3.71M
WBD icon
34
Warner Bros
WBD
$64.6B
$9.66M 0.3%
842,698
-1,579,804
-65% -$14.7M
OGN icon
35
Organon & Co
OGN
$3.55B
$9.65M 0.3%
996,965
+497,883
+100% +$5.14M
DOCN icon
36
DigitalOcean
DOCN
$14.4B
$9.63M 0.29%
337,254
+195,416
+138% +$5.71M
INSM icon
37
Insmed
INSM
$23.2B
$9.47M 0.29%
94,052
-40,517
-30% -$3.1M
VERA icon
38
Vera Therapeutics
VERA
$2.54B
$9.46M 0.29%
+401,427
New +$9.03M
GT icon
39
Goodyear
GT
$2.07B
$9.45M 0.29%
911,157
-70,362
-7% -$745K
SIRI icon
40
SiriusXM
SIRI
$10B
$9M 0.28%
391,988
+8,961
+2% +$193K
ETNB
41
DELISTED
89bio
ETNB
$8.86M 0.27%
902,076
+216,907
+32% +$1.8M
M icon
42
Macy's
M
$6.15B
$8.81M 0.27%
755,482
+309,602
+69% +$3.59M
MERC icon
43
Mercer International
MERC
$44.9M
$8.48M 0.26%
2,423,475
+1,166,936
+93% +$4.83M
MTN icon
44
Vail Resorts
MTN
$5.19B
$8.46M 0.26%
+53,817
New +$8M
LRN icon
45
Stride
LRN
$3.69B
$8.13M 0.25%
+55,977
New +$8.1M
TTD icon
46
Trade Desk
TTD
$8.13B
$7.87M 0.24%
109,280
-13,120
-11% -$838K
BSY icon
47
Bentley Systems
BSY
$9.54B
$7.41M 0.23%
+137,228
New +$6.35M
EFA icon
48
PUT
iShares MSCI EAFE ETF
EFA
$76.4B
$7.32M 0.22%
+81,900
New +$6.99M
INCY icon
49
Incyte
INCY
$23.5B
$6.95M 0.21%
+102,026
New +$6.46M
CLDX icon
50
Celldex Therapeutics
CLDX
$2.77B
$6.82M 0.21%
+335,000
New +$6.52M
1
2
3 4 5

Similar funds

DPCM
Darlington Partners Capital Management Greenbrae, California $2.23B AUM 16.2% 1-Year Est. Return
IFA
Index Fund Advisors Irvine, California $2.22B AUM 20.66% 1-Year Est. Return
NP
NS Partners London, United Kingdom $2.23B AUM 20.03% 1-Year Est. Return
ML
McAdam LLC Philadelphia, Pennsylvania $2.22B AUM 16.98% 1-Year Est. Return
GF
Greenhouse Funds Baltimore, Maryland $2.23B AUM 12.38% 1-Year Est. Return
NLGIA
Nippon Life Global Investors Americas New York $2.22B AUM 30.05% 1-Year Est. Return
BOI
Bank of Italy Rome, Italy $2.21B AUM 9.01% 1-Year Est. Return
GCM
Gladius Capital Management Chicago, Illinois $2.24B AUM 23.45% 1-Year Est. Return

Readystate Asset Management's Q2 2025 Portfolio in Review

As of Q2 2025, Readystate Asset Management held 979 positions worth $3.27B, up 8.8% from $3B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Readystate Asset Management withdrew a net $778M in Q2 2025, closing 388 positions and reducing 85 holdings. Its most notable exit was Intra-Cellular Therapies Inc., an estimated $66.9M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 13% of assets, up from 6.5% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Readystate Asset Management opened a new position in Hershey worth $73M.

  • Readystate Asset Management's largest Q2 2025 buy was Hershey: 440,026 shares worth $73M.
  • Readystate Asset Management added most to Exact Sciences in Q2 2025, an estimated $45.4M increase.
  • Readystate Asset Management's biggest Q2 2025 reduction was iShares iBoxx $ Investment Grade Corporate Bond ETF, cutting an estimated $31.8M.
  • Readystate Asset Management fully exited Intra-Cellular Therapies Inc. in Q2 2025, selling an estimated $66.9M.
  • Readystate Asset Management's ten largest holdings make up 40% of its $3.27B portfolio in Q2 2025.
  • Readystate Asset Management opened 382 new positions and closed 388 in Q2 2025.
  • Readystate Asset Management's portfolio value rose 8.8% quarter-over-quarter to $3.27B.

Based on Readystate Asset Management's 13F filing for Q2 2025, filed 7 Aug 2025.